Inventor
WINN MARTIN
US49 patents
⚠️ This page may combine multiple inventors who share the name “WINN MARTIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
38 patentsUS6162927ADec 19, 2000
Endothelin antagonists
ABBOTT LAB46 citations96
US5767144AJun 16, 1998
Endothelin antagonists
ABBOTT LAB90 citations96
US4665095AMay 12, 1987
Use of 2-[(3,5-dihalo-4-aminobenzyl)]imidazolines to stimulate alpha-1 adrenergic receptors and to treat nasal congestion
ABBOTT LAB50 citations96
US4093726AJun 6, 1978
N-(2-benzimidazolyl)-piperazines
ABBOTT LAB79 citations96
US5326776AJul 5, 1994
Angiotensin II receptor antagonists
ABBOTT LAB92 citations95
US5250548AOct 5, 1993
Angiotensin II receptor antagonists
ABBOTT LAB57 citations95
US4026894AMay 31, 1977
Antihypertensive agents
ABBOTT LAB80 citations94
US7511175B2Mar 31, 2009
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
ABBOTT LAB18 citations92
US7365093B2Apr 29, 2008
Endothelin antagonists
ABBOTT LAB18 citations92
US6946481B1Sep 20, 2005
Endothelin antagonists
ABBOTT LAB37 citations92
US6462194B1Oct 8, 2002
Endothelin antagonists
ABBOTT LAB14 citations92
US6124341ASep 26, 2000
Endothelin antagonists
ABBOTT LAB21 citations92
US5622971AApr 22, 1997
Endothelin antagonists
ABBOTT LAB25 citations92
US6329534B1Dec 11, 2001
Glucocorticoid receptor antagonists for treatment of diabetes
ABBOTT LAB40 citations90
US7880001B2Feb 1, 2011
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
ABBOTT LAB9 citations83
US7855308B2Dec 21, 2010
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
ABBOTT LAB9 citations83
US6878700B1Apr 12, 2005
Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
ABBOTT LAB14 citations83
US6380241B1Apr 30, 2002
Treatment of diseases using endothelin antagonists
ABBOTT LAB13 citations82
US6110922AAug 29, 2000
Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
ABBOTT LAB16 citations82
US5731434AMar 24, 1998
Endothelin antagonists
ABBOTT LAB15 citations82
US4180669ADec 25, 1979
2-(N-phenethyl-4-piperidino)-5-pentyl resorcinol
ABBOTT LAB22 citations82
US4622405ANov 11, 1986
1,2,3,3a,8,8a-hexahydro-indeno[1,2-c]pyrroles useful in the treatment of hypertension
ABBOTT LAB16 citations74
US4440769AApr 3, 1984
2-(4-Phenylalkanoylpiperazin-1-yl) quinazoline compounds, pharmaceutical compositions and method of producing α1 antagonistic activity
ABBOTT LAB8 citations74
US4081449AMar 28, 1978
Heterocyclic esters of alkylphenyl benzopyranopyridines
ABBOTT LAB8 citations74
US4473586ASep 25, 1984
Aminoalkyl dihydronaphthalenes
ABBOTT LAB13 citations73
US4088765AMay 9, 1978
5,6-Dimethoxy-2-heterocyclic benzimidazoles
ABBOTT LAB14 citations73
US4145422AMar 20, 1979
Aminomethylene oxindoles
ABBOTT LAB11 citations72
US4112097ASep 5, 1978
Antihypertensive agents
ABBOTT LAB12 citations72
US3947462AMar 30, 1976
2,4,7-substituted 5-hydroxy benzopyrans and esters
ABBOTT LAB6 citations70
US4049653ASep 20, 1977
Heterocyclic esters of alkylphenyl benzopyrans
ABBOTT LAB6 citations63
US3932432AJan 13, 1976
Alkylphenyl benzopyranopyridines
ABBOTT LAB4 citations63
US4176191ANov 27, 1979
Aminomethylene oxindoles
ABBOTT LAB2 citations61
US4171367AOct 16, 1979
Pyrazolyl amino imidazolines
ABBOTT LAB5 citations57
US4029665AJun 14, 1977
8-Aralkyl-1,4-ethano-5H-[1]benzopyrano[3,4-b]pyridines
ABBOTT LAB1 citations52
USRE39197EJul 18, 2006
Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
ABBOTT LAB0 citations51
US4234594ANov 18, 1980
Pyrazolyl amino imidazolines as antihypertensive agents
ABBOTT LAB1 citations48
US4044135AAug 23, 1977
Antihypertensive agents
ABBOTT LAB1 citations46
US6593480B2Jul 15, 2003
Glucocorticoid receptor antagonists for treatment of diabetes
ABBOTT LAB0 citations37
SHARPS ASS
3 patentsUS4007207AFeb 8, 1977
Alkyl substituted-4-oxo-cyclopenta benzopyrans
SHARPS ASS2 citations60
US3946111AMar 23, 1976
Pharmaceutical compositions containing 1 or 2-mono and dialkyl substituted thienobenzopyrans and pharmacological uses thereof
SHARPS ASS4 citations60
US3992550ANov 16, 1976
Pharmaceutical compositions containing alryl substituted cyclopenta benzopyrans
SHARPS ASS1 citations49
ABBVIE INC
3 patentsUS9290444B2Mar 22, 2016
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
ABBVIE INC0 citations50
US9133145B2Sep 15, 2015
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
ABBVIE INC0 citations49
US9464072B2Oct 11, 2016
Treatment of central nervous system disorders
ABBVIE INC0 citations48
BITNER R SCOTT
3 patentsUS8716345B2May 6, 2014
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
BITNER R SCOTT0 citations48
US8415354B2Apr 9, 2013
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
BITNER R SCOTT1 citations48
US8940902B2Jan 27, 2015
Treatment of central nervous system disorders
BITNER R SCOTT0 citations47